Skip to content
Screener

McKesson MCK Medical-Surgical Solutions — Asset impairments and accelerated depreciation

Similar metrics at other companies

Medtronic logo
MDTMedical Surgical — Depreciation
$56M+5.7%
Nordson logo
NDSNMedical and Fluid Solutions — Depreciation
$7.83M-9.7%
Medtronic logo
MDTMedical Surgical — Net Sales
$2.39B+8.0%
Medtronic logo
MDTMedical Surgical — Research and development expense
$163M-3.6%
Medtronic logo
MDTMedical Surgical — Currency translation and other
$110M-84.8%
Surgery Partners, Inc. logo
SGRYSurgical Facilities — Professional and medical fees
$101.3M+6.3%

Other financials

Income statement

See full
Revenue$105.38B+7.7%
Gross profit$3.7B+12.4%
Operating income$1.3B+27.3%
Net income$614.0M-21.7%
EPS (diluted)$5.15-17.6%

Balance sheet

See full
Cash & equivalents$5.3B+95.9%
Total debt$13.0B+15.7%
Total equity-$4.2B-116%
Total assets$88.3B+8.6%

Cash flow

See full
Operating cash flow-$220.0M+76.0%
CapEx$112.0M+0.9%
Free cash flow-$332.0M+67.7%

Valuation

See full
Market cap$101.59B+15.6%
Enterprise value$109.31B+13.4%
P/E22.1×-5.7×
P/S0.3×0.0×

Profitability

See full
Gross margin3.6%+0.1pp
Operating margin1.6%+0.4pp
Net margin1.1%+0.3pp
FCF margin1.6%0.0pp

Returns & leverage

See full
Return on equity36%
Debt / equity
Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept mck:AssetImpairmentChargesIncludingAcceleratedDepreciation.

The source filing: McKesson’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:29 PM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0000927653-26-000234
(In millions)Three Months Ended June 30, 2026 / North American Pharmaceutical (1)Three Months Ended June 30, 2026 / Prescription Technology Solutions (1)Three Months Ended June 30, 2026 / Medical-Surgical Solutions (1)Three Months Ended June 30, 2026 / Corporate (1)Total
Severance and employee-related costs, net$11$14$7$32
Exit and other-related costs (2)11093757
Asset impairments and accelerated depreciation140647
Total$2$61$23$50$136

Item 1. Condensed Consolidated Financial Statements.

FAQ

What is McKesson's medical-surgical solutions — asset impairments and accelerated depreciation?
McKesson (MCK) reported medical-surgical solutions — asset impairments and accelerated depreciation of $0 in Q2 2026.
What is the long-term trend for McKesson's medical-surgical solutions — asset impairments and accelerated depreciation?
Over 3 years (2022 to 2025), McKesson's medical-surgical solutions — asset impairments and accelerated depreciation has grown at a 40.9% compound annual growth rate (CAGR), from $5M to $14M.
What does medical-surgical solutions — asset impairments and accelerated depreciation mean?
This metric reflects non-cash charges resulting from the write-down of asset values or the shortening of useful lives for assets within the Medical-Surgical Solutions segment. It often signals that specific assets are no longer expected to provide the same future economic benefit as originally anticipated.

Ask your AI about McKesson's medical-surgical solutions — asset impairments and accelerated depreciation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude